BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29378601)

  • 1. Tissue expression of retinoic acid receptor alpha and CRABP2 in metastatic nephroblastomas.
    Percicote AP; Mardegan GL; Gugelmim ES; Ioshii SO; Kuczynski AP; Nagashima S; de Noronha L
    Diagn Pathol; 2018 Jan; 13(1):9. PubMed ID: 29378601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nephroblastomas (Wilms' tumors) and special variations of nephroblastomas].
    Schmidt D
    Veroff Pathol; 1989; 133():1-174. PubMed ID: 2556868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between cytoplasmic CRABP2, altered retinoic acid signaling, and poor prognosis in glioblastoma.
    Liu RZ; Li S; Garcia E; Glubrecht DD; Poon HY; Easaw JC; Godbout R
    Glia; 2016 Jun; 64(6):963-76. PubMed ID: 26893190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and clinical significance of CRABP1 and CRABP2 in non-small cell lung cancer.
    Favorskaya I; Kainov Y; Chemeris G; Komelkov A; Zborovskaya I; Tchevkina E
    Tumour Biol; 2014 Oct; 35(10):10295-300. PubMed ID: 25034531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and prognostic value of epidermal growth factor receptor, transforming growth factor-alpha, and c-erb B-2 in nephroblastoma.
    Ghanem MA; Van Der Kwast TH; Den Hollander JC; Sudaryo MK; Mathoera RB; Van den Heuvel MM; Noordzij MA; Nijman RJ; van Steenbrugge GJ
    Cancer; 2001 Dec; 92(12):3120-9. PubMed ID: 11753991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Histology and prognosis of nephroblastoma--with special reference to special variants].
    Schmidt D; Harms D
    Klin Padiatr; 1983; 195(3):214-21. PubMed ID: 6308334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Histopathology of nephroblastomas (author's transl)].
    Harms D; Zeidler H
    Klin Padiatr; 1981 May; 193(3):206-12. PubMed ID: 6267354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaplastic nephroblastomas express transketolase-like enzyme 1.
    Wu HT; Allie N; Myer L; Govender D
    J Clin Pathol; 2009 May; 62(5):460-3. PubMed ID: 19139037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Cellular Retinoic Acid Binding Protein 2 Promotes Survival of Malignant Peripheral Nerve Sheath Tumor Cells.
    Fischer-Huchzermeyer S; Dombrowski A; Hagel C; Mautner VF; Schittenhelm J; Harder A
    Am J Pathol; 2017 Jul; 187(7):1623-1632. PubMed ID: 28502478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRABP1 is associated with a poor prognosis in breast cancer: adding to the complexity of breast cancer cell response to retinoic acid.
    Liu RZ; Garcia E; Glubrecht DD; Poon HY; Mackey JR; Godbout R
    Mol Cancer; 2015 Jul; 14():129. PubMed ID: 26142905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular Retinoic-Acid Binding Protein 2 in Solid Tumor.
    Jiao X; Liu R; Huang J; Lu L; Li Z; Xu L; Li E
    Curr Protein Pept Sci; 2020; 21(5):507-516. PubMed ID: 32013828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of the heat shock protein 70 in the histological compartments of nephroblastomas.
    Efferth T; Schulten HG; Thelen P; Bode ME; Beniers AJ; Granzen B; Ringert RH; Mertens R; Gefeller O; Jakse G; Fuzesi L
    Anticancer Res; 2001; 21(4B):2915-20. PubMed ID: 11712786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRABP2 - A novel biomarker for high-risk endometrial cancer.
    Egan D; Moran B; Wilkinson M; Pinyol M; Guerra E; Gatius S; Matias-Guiu X; Kolch W; le Roux CW; Brennan DJ
    Gynecol Oncol; 2022 Nov; 167(2):314-322. PubMed ID: 36163055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular Retinoic Acid Binding Protein 2 Is Strikingly Downregulated in Human Esophageal Squamous Cell Carcinoma and Functions as a Tumor Suppressor.
    Yang Q; Wang R; Xiao W; Sun F; Yuan H; Pan Q
    PLoS One; 2016; 11(2):e0148381. PubMed ID: 26839961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical detection of p53 protein expression as a prognostic indicator in Wilms tumor.
    Sredni ST; de Camargo B; Lopes LF; Teixeira R; Simpson A
    Med Pediatr Oncol; 2001 Nov; 37(5):455-8. PubMed ID: 11745874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minichromosome maintenance 2 (MCM2) is a new prognostic proliferative marker in Wilms tumour.
    Taran K; Sitkiewicz A; Andrzejewska E; Kobos J
    Pol J Pathol; 2011; 62(2):84-8. PubMed ID: 21866463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and prognostic value Of CD44 isoforms in nephroblastoma (Wilms tumor).
    Ghanem MA; Van Steenbrugge GJ; Van Der Kwast TH; Sudaryo MK; Noordzij MA; Nijman RJ
    J Urol; 2002 Aug; 168(2):681-6. PubMed ID: 12131349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stromal-type Nephroblastoma with or without Anaplasia in Two Hedgehogs (Atelerix albiventris).
    Ueda K; Imada T; Ueda A; Imada M; Ozaki K
    J Comp Pathol; 2019 Oct; 172():48-52. PubMed ID: 31690414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of proliferating cell nuclear antigen in Wilms' tumors and other pediatric renal tumors: the correlation between histologic classification and proliferative activity.
    Nagoshi M; Tsuneyoshi M
    J Surg Oncol; 1994 Feb; 55(2):114-21. PubMed ID: 7907158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the lipogenic enzyme fatty acid synthase (FAS) as a predictor of poor outcome in nephroblastoma: an interinstitutional study.
    Camassei FD; Jenkner A; Ravà L; Bosman C; Francalanci P; Donfrancesco A; Alò PL; Boldrini R
    Med Pediatr Oncol; 2003 May; 40(5):302-8. PubMed ID: 12652618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.